Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hospitalisation and healthcare burden of respiratory syncytial virus in adults aged 50 years and older in France, 2015-2022.

Infectious diseases (London, England)·2026

Same author

Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.

Brain : a journal of neurology·2026

Same author

Pregnant Women COVID-19 immunisation in 2026: evidence, uncertainty and priorities.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Same author

Respiratory syncytial virus in adults aged ≥ 50 years in France: a database and time-series modelling analysis (2014-2020).

Infection·2026

Same author

Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.

PloS one·2026

Same author

RSV vaccination in immunocompromised adults.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Same journal

[Prolonged fever].

La Revue du praticien·2026

Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026

Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026

Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026

Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026

Same journal

[Patient education in heart failure].

La Revue du praticien·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Atypical bacterial pneumonias].

Romaric Larcher¹, Paul Loubet¹

¹Service des maladies infectieuses et tropicales, hôpital Carémeau, CHU de Nîmes, Nîmes, France.

La Revue Du Praticien

|June 6, 2025

Summary

This summary is machine-generated.

Atypical bacterial pneumonias present nonspecific symptoms, complicating diagnosis and treatment. Early consideration and specific tests are crucial for effective management with antibiotics like macrolides.

Keywords:

Pneumonia, Bacterial

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Experiment Videos

Last Updated: Jun 12, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Area of Science:

Infectious Diseases
Pulmonology
Microbiology

Background:

Atypical bacterial pneumonias are caused by diverse pathogens, including Mycoplasma pneumoniae and Legionella pneumophila.
These infections present nonspecific clinical, biological, and radiological features, challenging differentiation from typical pneumonia.
Pathogens are often missed by standard microbiological methods and exhibit resistance to beta-lactam antibiotics.

Purpose of the Study:

To highlight the diagnostic and therapeutic complexities of atypical bacterial pneumonias.
To emphasize the importance of considering atypical pathogens in pneumonia management.
To outline appropriate antibiotic strategies and diagnostic confirmation methods.

Main Methods:

Review of clinical presentations, diagnostic challenges, and treatment approaches for atypical bacterial pneumonias.
Discussion of pathogens such as Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila, Chlamydia psittaci, Coxiella burnetii, and Francisella tularensis.
Emphasis on the role of specific diagnostic tests like PCR, urinary antigen tests, and serologies.

Main Results:

Atypical bacterial pneumonias often mimic typical pneumonia, complicating initial assessment.
Standard microbiological techniques frequently fail to detect causative atypical pathogens.
Effective treatment relies on specific antibiotics (macrolides, tetracyclines, fluoroquinolones) and targeted diagnostic confirmation.

Conclusions:

Clinicians must maintain a high index of suspicion for atypical bacterial pneumonias due to nonspecific presentations.
Prompt and accurate diagnosis using specialized tests is essential for appropriate therapeutic intervention.
Tailored antibiotic selection and diagnostic confirmation significantly improve patient outcomes in atypical pneumonia cases.